EICHOR
● Active Not Recruiting
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
Condition: Prostatic Neoplasms · Neoplasm Metastasis · Urogenital Neoplasms · Sponsor: Eli Lilly and Company
About this study
The purpose of this study is to learn whether adding abemaciclib to abiraterone plus prednisone prolongs the time before prostate cancer gets worse. Participation may last approximately 60 months.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (266)
| Arizona Oncology Associates, P.C. - HOPE | Prescott, Arizona, United States | — |
| Arizona Oncology Associates, P.C. - HOPE | Prescott Valley, Arizona, United States | — |
| The University of Arizona Cancer Center - North Campus | Tucson, Arizona, United States | — |
| Genesis Cancer and Blood Institute | Hot Springs, Arkansas, United States | — |
| St. Bernards Medical Center | Jonesboro, Arkansas, United States | — |
| Highlands Oncology Group | Springdale, Arkansas, United States | — |
| Orange Coast Memorial Medical Center | Fountain Valley, California, United States | — |
| Providence Medical Foundation | Fullerton, California, United States | — |
| Moores Cancer Center | La Jolla, California, United States | — |
| MemorialCare Health System - Long Beach Medical Center | Long Beach, California, United States | — |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | — |
| UCLA Hematology/Oncology - Santa Monica | Los Angeles, California, United States | — |
+ 254 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05288166